Oncotarget
The cover for issue 42 of Oncotarget features Figure 6, "Model for CEMIP-mediated upregulation of BiP leading to increased cell survival during hypoxia/stress," by Banach, et al.
Genetic manipulation of the mammary gland and potential applications |
https://doi.org/10.18632/oncotarget.27044 Hiroaki Tagaya, Kentaro Semba, and Kosuke Ishikawa |
4253-4254 |
PDF | How to cite | Order a Reprint |
Modified Simon’s minimax and optimal two-stage designs for single-arm phase II cancer clinical trials |
https://doi.org/10.18632/oncotarget.26981 Jongphil Kim, and Michael J. Schell |
4255-4261 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Order a Reprint |
PARP-1 inhibitor modulate β-catenin signaling to enhance cisplatin sensitivity in cancer cervix |
https://doi.org/10.18632/oncotarget.27008 Minakshi Mann, Sachin Kumar, Shyam S. Chauhan, Neerja Bhatla, Sunesh Kumar, Sameer Bakhshi, Ritu Gupta, Ashok Sharma, and Lalit Kumar |
4262-4275 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Order a Reprint |
AGR2, a unique tumor-associated antigen, is a promising candidate for antibody targeting |
https://doi.org/10.18632/oncotarget.26945 Alvin Y. Liu, Adelle D. Kanan, Tomasz P. Radon, Siama Shah, Mark E. Weeks, Julie M. Foster, Jane K. Sosabowski, Laurent Dumartin, and Tatjana Crnogorac-Jurcevic |
4276-4289 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Order a Reprint |
Comparative RNA-seq analysis reveals dys-regulation of major canonical pathways in ERG-inducible LNCaP cell progression model of prostate cancer |
https://doi.org/10.18632/oncotarget.27019 Parameet Kumar, Joyeeta Chakraborty, Gauthaman Sukumar, Clifton Dalgard, Raghunath Chatterjee, and Roopa Biswas |
4290-4306 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Order a Reprint |
CEMIP upregulates BiP to promote breast cancer cell survival in hypoxia |
https://doi.org/10.18632/oncotarget.27036 Anna Banach, Ya-Ping Jiang, Eric Roth, Cem Kuscu, Jian Cao, and Richard Z. Lin |
4307-4320 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Order a Reprint |
Contribution of trastuzumab to the prognostic improvement of HER2-positive early breast cancer in Spain: an estimation of life years and disease-free life years gained since its approval |
https://doi.org/10.18632/oncotarget.27039 Eva Ciruelos, Emilio Alba, Rafael López, Anna Lluch, Miguel Martín, Isabel Arroyo, Beatriz Navarro, David Carcedo, Ramón Colomer, and Joan Albanell |
4321-4332 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Order a Reprint |
The emerging role of human cytomegalovirus infection in human carcinogenesis: a review of current evidence and potential therapeutic implications |
https://doi.org/10.18632/oncotarget.27016 Cecilia Söderberg Nauclér, Jürgen Geisler, and Katja Vetvik |
4333-4347 |
Abstract | PDF | Full Text | How to cite | Order a Reprint |
Correction: Inhibition of EHMT2/G9a epigenetically increases the transcription of Beclin-1 via an increase in ROS and activation of NF-κB |
https://doi.org/10.18632/oncotarget.27046 Sang Eun Park, Hye Jin Yi, Nayoung Suh, Yun-Yong Park, Jae-Young Koh, Seong-Yun Jeong, Dong-Hyung Cho, Choung-Soo Kim, and Jung Jin Hwang |
4348-4349 |
Correction | PDF | How to cite |
Correction: Stratifying nonfunctional pituitary adenomas into two groups distinguished by macrophage subtypes |
https://doi.org/10.18632/oncotarget.27048 Garima Yagnik, Martin Rutkowski, Sumedh S. Shah, and Manish K. Aghi |
4350-4350 |
Correction | PDF | How to cite |
Copyright © 2021 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC